Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

9.770 -0.060 (-0.61%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	1,413,659
Open	9.830
Bid (Size)	9.400 (300)
Ask (Size)	10.25 (500)
Prev. Close	9.830
Today's Range	9.510 - 10.03
52wk Range	2.215 - 11.46
Shares Outstanding	57,943,066
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 10, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

November 06, 2025

From Rezolute, Inc.

Via GlobeNewswire

Performance

YTD	+89.7%	+89.7%
1 Month	+3.4%	+3.4%
3 Month	+39.6%	+39.6%
6 Month	+155.1%	+155.1%
1 Year	+101.0%	+101.0%

More News

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

November 05, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

October 15, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

October 09, 2025

From Rezolute, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Rezolute Inc (NASDAQ:RZLT) Reports Q4 FY2025 Results, Posts Wider-Than-Expected Loss Amid Strong Clinical Progress ↗

September 17, 2025

Via Chartmill

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

September 17, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Stock: FDA Fast Track Fuels 2025 Breakout ↗

September 17, 2025

Via MarketBeat

Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism

September 02, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

August 27, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer

August 20, 2025

From Rezolute, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

August 13, 2025

Via Benzinga

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

July 22, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)

July 09, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism

May 28, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update

May 13, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

May 05, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

May 01, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute, Inc. Announces Closing of Underwritten Offering

April 25, 2025

From Rezolute, Inc.

Via GlobeNewswire

Rezolute 'Thrilled' With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December ↗

April 23, 2025

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

April 23, 2025

Via Chartmill

What's going on in today's pre-market session ↗

April 23, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 23, 2025

Via Benzinga

Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants

April 23, 2025

From Rezolute, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Rezolute, Inc. - Common Stock (NV) publicly traded?

Yes, Rezolute, Inc. - Common Stock (NV) is publicly traded.

What exchange does Rezolute, Inc. - Common Stock (NV) trade on?

Rezolute, Inc. - Common Stock (NV) trades on the Nasdaq Stock Market

What is the ticker symbol for Rezolute, Inc. - Common Stock (NV)?

The ticker symbol for Rezolute, Inc. - Common Stock (NV) is RZLT on the Nasdaq Stock Market

What is the current price of Rezolute, Inc. - Common Stock (NV)?

The current price of Rezolute, Inc. - Common Stock (NV) is 9.770

When was Rezolute, Inc. - Common Stock (NV) last traded?

The last trade of Rezolute, Inc. - Common Stock (NV) was at 11/24/25 04:00 PM ET

What is the market capitalization of Rezolute, Inc. - Common Stock (NV)?

The market capitalization of Rezolute, Inc. - Common Stock (NV) is 566.10M

How many shares of Rezolute, Inc. - Common Stock (NV) are outstanding?

Rezolute, Inc. - Common Stock (NV) has 566M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.